Portfolio company
Garuda Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops off-the-shelf blood stem cell therapies to treat patients with hematologic malignancies, sickle cell disease, and bone marrow failure disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
Orchard Therapeutics
Orchard Therapeutics develops haematopoietic stem cell gene therapies for patients living with severe genetic diseases.
Ossium Health
This company develops bone marrow-derived cell therapies and bone allografts for healthcare providers, life science companies and researchers treating blood and immune diseases.
Bluebird Bio
This company develops and manufactures gene therapies for patients with severe genetic diseases, including sickle cell disease and beta-thalassaemia.
Caribou Biosciences
This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.
Clade Therapeutics
This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.
Promethera
The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.
Arda Therapeutics
This biotechnology company develops targeted cell depletion therapies to treat chronic diseases by identifying and removing specific pathogenic cells in patients.
